AVEO AVEO Pharmaceuticals Inc.

$-100%

1,459,085 Shares Traded
1,856,760 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $20.84 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-4.38%
If Intiated One Month Ago, Shorts Have Realized a Return of:3.7%
If Initiated Five Days ago, Shorts Have Realized a Return of:4.67%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 6.11%
Short Interest7.09 million
Float115.98 million
Short Ratio4.12
Market Cap$338.41 million
Market Maker ActivityDaily Short Volume

News

02-13-2018
ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines (SeekingAlpha)
02-13-2018
Your Daily Pharma Scoop: A Look At Celldex, BeiGene Data, Axovant Announces Changes At Top (SeekingAlpha)
02-13-2018
3 Things In Biotech You Should Learn Today: February 12, 2018 (SeekingAlpha)
02-12-2018
Week 7 Breakout Forecast:  Short-Term Picks To Give You An Edge (SeekingAlpha)
02-12-2018
AVEO earns $2M milestone on NICE backing of Fotivda in aRCC; shares ahead 6% premarket (SeekingAlpha)
02-12-2018
AVEO Announces EUSA Pharma Granted Positive NICE Recommendation for FOTIVDA® (tivozanib) as First Line Treatment for Advanced Renal Cell Carcinoma (Business Wire)
02-12-2018
In This Stock Market, It's Time To Declare War On Biotech Bagholding (SeekingAlpha)
02-11-2018
AVEO Pharmaceuticals: TiNivo Results Impress, TIVO-3 Next (SeekingAlpha)
02-10-2018
AVEO Oncology and EUSA Pharma Announce Encouraging Preliminary Results from Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma (Business Wire)
02-07-2018
AVEO Oncology to Present at Upcoming Conferences (Business Wire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 65%

Earnings Stats

PE Ratio -8.67
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $2.64
50 Day Moving Average $2.95
52 Week High $4.24
52 Week Low $0.5



Data provided for free by IEX. Questions? Read the FAQ